|
|
||||||||
The FASEB Journal, Vol 10, 760-768, Copyright © 1996 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
KP Conrad, DF Benyo, A Westerhausen-Larsen and TM Miles
Magee-Womens Research Institute, Pittsburgh, Pennsylvania 15213, USA.
Circulating levels of maternal erythropoietin (EPO) rise during gestation due to increased biosynthesis of the hormone. Our objective was to investigate the human placenta as a potential extrarenal site of EPO production. Using two monoclonal antibodies recognizing different antigenic determinants, we identified immunoreactive EPO associated with villous cytotrophoblast, endovascular and intravascular cytotrophoblast, cytotrophoblast cell columns, and syncytiotrophoblast of first and second-trimester placenta as well as syncytiotrophoblast and extravillous cytotrophoblast of normal third-trimester and preeclamptic placenta. In addition, cultured JAR (trophoblast-derived) choriocarcinoma cells, cytotrophoblasts isolated from term placenta, villous core cells, and possibly other nontrophoblast cells within the decidual basal plate expressed immunoreactive EPO. Using reverse transcription-polymerase chain reaction and EPO-specific primers, a 378 bp DNA product was amplified from placental tissues of various gestational ages, cytotrophoblasts isolated from term placenta, and JAR choriocarcinoma cells. The amplified product yielded restriction enzyme fragments of predicted sizes. On Southern analysis, hybridization was observed for two of these fragments in which the radiolabeled EPO cDNA probe did not overlap with the primer sequences. Finally, the JAR choriocarcinoma cells elaborated EPO into the culture medium as determined by enzyme-linked immunosorbant assay and expressed EPO mRNA as determined by Northern analysis, both of which were stimulated by hypoxia (15-20 torr). Taken together, these results suggest a new site of EPO expression: the trophoblast cell of the human placenta.
This article has been cited by other articles:
![]() |
N. Paffett-Lugassy, N. Hsia, P. G. Fraenkel, B. Paw, I. Leshinsky, B. Barut, N. Bahary, J. Caro, R. Handin, and L. I. Zon Functional conservation of erythropoietin signaling in zebrafish Blood, October 1, 2007; 110(7): 2718 - 2726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hardee, M. O. Arcasoy, K. L. Blackwell, J. P. Kirkpatrick, and M. W. Dewhirst Erythropoietin Biology in Cancer Clin. Cancer Res., January 15, 2006; 12(2): 332 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sairanen, M.-L. Karjalainen-Lindsberg, A. Paetau, P. Ijas, and P. J. Lindsberg Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments Brain, January 1, 2006; 129(1): 189 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kumar, G. Acs, D. Fang, M. Herlyn, D. E. Elder, and X. Xu Functional Erythropoietin Autocrine Loop in Melanoma Am. J. Pathol., March 1, 2005; 166(3): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fandrey Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R977 - R988. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J Smith, A. J Bleyer, W. C Little, and D. C Sane The cardiovascular effects of erythropoietin Cardiovasc Res, September 1, 2003; 59(3): 538 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsuzaki, M. Canis, R. Yokomizo, N. Yaegashi, M. A. Bruhat, and K. Okamura Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis Hum. Reprod., January 1, 2003; 18(1): 152 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Semba and S. E. Juul Erythropoietin in Human Milk: Physiology and Role in Infant Health J Hum Lact, August 1, 2002; 18(3): 252 - 261. [Abstract] [PDF] |
||||
![]() |
R. Yokomizo, S. Matsuzaki, S. Uehara, T. Murakami, N. Yaegashi, and K. Okamura Erythropoietin and erythropoietin receptor expression in human endometrium throughout the menstrual cycle Mol. Hum. Reprod., May 1, 2002; 8(5): 441 - 446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Magnanti, O. Gandini, L. Giuliani, P. Gazzaniga, H. H. Marti, A. Gradilone, L. Frati, A. M. Agliano, and M. Gassmann Erythropoietin expression in primary rat Sertoli and peritubular myoid cells Blood, November 1, 2001; 98(9): 2872 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Sohl, C. Y. Cheung, J. A. Widness, and R. A. Brace Erythropoietin responses to progressive blood loss over 10 days in the ovine fetus Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1051 - R1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsuzaki, T. Murakami, S. Uehara, R. Yokomizo, T. Noda, Y. Kimura, and K. Okamura Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis Hum. Reprod., May 1, 2001; 16(5): 945 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. VUORELA, S. HELSKE, C. HORNIG, K. ALITALO, H. WEICH, and E. HALMESMAKI Amniotic Fluid-Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia Obstet. Gynecol., March 1, 2000; 95(3): 353 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fairchild Benyo and K. P. Conrad Expression of the Erythropoietin Receptor by Trophoblast Cellsin the Human Placenta Biol Reprod, April 1, 1999; 60(4): 861 - 870. [Abstract] [Full Text] |
||||
![]() |
M. Fried, R. O. Muga, A. O. Misore, and P. E. Duffy Malaria Elicits Type 1 Cytokines in the Human Placenta: IFN-{gamma} and TNF-{alpha} Associated with Pregnancy Outcomes J. Immunol., March 1, 1998; 160(5): 2523 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Moritz, G. B. Lim, and E. M. Wintour Developmental regulation of erythropoietin and erythropoiesis Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1997; 273(6): R1829 - R1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Benyo, T. M. Miles, and K. P. Conrad Hypoxia Stimulates Cytokine Production by Villous Explants from the Human Placenta J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1582 - 1588. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |